L. Groussin

发表

Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery.

E. Hindié, P. Lamy, J. Clerc, 2017, Annales d'endocrinologie.

Management of Cushing's syndrome due to ectopic adrenocorticotropin secretion with 1,ortho-1, para'-dichloro-diphenyl-dichloro-ethane: findings in 23 patients from a single center.

J. Bertherat, X. Bertagna, B. Donadille, 2010, The Journal of clinical endocrinology and metabolism.

Pathogenesis of benign adrenocortical tumors.

J. Bertherat, L. Groussin, D. Vezzosi, 2010, Best practice & research. Clinical endocrinology & metabolism.

Molecular and Functional Analysis of PRKAR 1 A and its Locus ( 17 q 22 – 24 ) in Sporadic Adrenocortical Tumors : 17 q Losses , Somatic Mutations , and Protein Kinase A Expression and Activity 1

J. Bertherat, X. Bertagna, C. Stratakis, 2003 .

Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.

J. Bertherat, X. Bertagna, C. Stratakis, 2003, Cancer research.

cAMP PATHWAY ALTERATIONS FROM THE CELL SURFACE TO THE NUCLEUS IN ADRENOCORTICAL TUMORS

J. Bertherat, X. Bertagna, L. Groussin, 2002, Endocrine research.

Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses

O. Vignaux, X. Bertagna, P. Legmann, 2015, International journal of endocrinology.

Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy.

M. Bienvenu, X. Bertagna, P. Legmann, 2009, The Journal of clinical endocrinology and metabolism.

[Pregnancy and thyroid disorders].

L. Groussin, L. Bricaire, 2015, La Revue de medecine interne.

Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients

O. Mäkitie, L. Rejnmark, M. Zillikens, 2020, Hormone Research in Paediatrics.

Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement

O. Mäkitie, L. Rejnmark, M. Zillikens, 2018, Nature Reviews Endocrinology.

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

J. Bertherat, X. Bertagna, C. Cavard, 2005, Cancer research.

Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome.

H. Vaudry, J. Bertherat, L. Groussin, 2006, The Journal of clinical endocrinology and metabolism.

Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.

J. Bertherat, G. Assié, L. Groussin, 2009, Cancer research.

Long-Term Imaging Follow-Up in DIPNECH: Multicenter Experience

L. Fournel, M. Lederlin, M. Revel, 2021, Journal of clinical medicine.

18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients.

H. Gouya, J. Bertherat, X. Bertagna, 2004, European journal of endocrinology.

[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement].

P. Chanson, C. Annweiler, O. Beauchet, 2014, Annales de biologie clinique.

[Recommendations for the measurement of blood 25-OH vitamin D].

G. Deschênes, J. Souberbielle, D. Fouque, 2016, Annales de biologie clinique.

In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.

H. Vaudry, J. Bertherat, X. Bertagna, 2005, The Journal of clinical endocrinology and metabolism.

Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma.

L. Groussin, C. Baudry, A. Paepegaey, 2013, The New England journal of medicine.

Laparoscopic adrenalectomy for adrenocortical carcinoma: a medico-surgical perspective.

J. Bertherat, B. Dousset, L. Groussin, 2012, Annales d'endocrinologie.

Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer.

E. Pasmant, K. Leroy, F. Goldwasser, 2022, Thyroid : official journal of the American Thyroid Association.

DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers

J. Bertherat, F. Tissier, F. Cormier, 2017, PloS one.

DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.

A. Tabarin, E. Korpershoek, E. Baudin, 2016, The Journal of clinical endocrinology and metabolism.

Loss of Heterozygosity of 17p13, With Possible Involvement of ACADVL and ALOX15B, in the Pathogenesis of Adrenocortical Tumors

J. Bertherat, X. Bertagna, A. Gill, 2008, Annals of surgery.

Transcription factor 3',5'-cyclic adenosine 5'-monophosphate-responsive element-binding protein (CREB) is decreased during human adrenal cortex tumorigenesis and fetal development.

J. Bertherat, X. Bertagna, A. Louvel, 2003, The Journal of clinical endocrinology and metabolism.

The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas.

M. Sibony, J. Bertherat, X. Bertagna, 2015, European journal of endocrinology.

Management of thyroid dysfunctions in the elderly. French Endocrine Society consensus statement 2019. Long version.

A. Cailleux, P. Caron, B. Goichot, 2020, Annales d'endocrinologie.

A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia

I. Bossis, J. Bertherat, X. Bertagna, 2006, Nature Genetics.

Best Practice & Research Clinical Endocrinology & Metabolism

X. Bertagna, F. Sweep, L. Groussin, 2009 .

Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib—Letter

F. Goldwasser, J. Clerc, L. Groussin, 2015, Clinical Cancer Research.

Significance of BRAF mutations in papillary thyroid carcinoma: prognostic and therapeutic implications

J. Fagin, L. Groussin, 2006, Nature Clinical Practice Endocrinology &Metabolism.

Management of thyroid dysfunctions in the elderly.French Endocrine Society consensus 2019 guidelines*.Short version.

A. Cailleux, P. Caron, B. Goichot, 2020, Annales d'endocrinologie.

Phosphodiesterase 11A (PDE11A) and Genetic Predisposition to Adrenocortical Tumors

J. Bertherat, X. Bertagna, C. Stratakis, 2008, Clinical Cancer Research.

Genetic evaluation in primary hyperparathyroidism: What investigation? For which patients?

L. Groussin, 2015, Annales d'endocrinologie.

Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients HORMONERESEARCH IN PÆDIATRIC S

O. Mäkitie, R. Pignolo, H. Jüppner, 2020 .

Critical role of sorafenib exposure over time for its antitumor activity in thyroid cancer

O. Mir, F. Goldwasser, J. Clerc, 2014, Investigational New Drugs.

Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.

F. Faucz, J. Bertherat, X. Bertagna, 2011, The Journal of clinical endocrinology and metabolism.

Somatic TP53 Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17p13 Loss of Heterozygosity

C. Elie, J. Bertherat, X. Bertagna, 2007, Clinical Cancer Research.

Somatic TP 53 Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17 p 13 Loss of Heterozygosity

C. Elie, X. Bertagna, C. Gicquel, 2007 .

Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective study.

P. Chanson, A. Tabarin, E. Baudin, 2015, European journal of endocrinology.

18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism.

M. Bienvenu, J. Clerc, L. Groussin, 2022, Diagnostic and interventional imaging.

Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.

J. Bertherat, X. Bertagna, C. Stratakis, 2009, The Journal of clinical endocrinology and metabolism.

Systematic Analysis of G Protein-Coupled Receptor Gene Expression in Adrenocorticotropin-Independent Macronodular Adrenocortical Hyperplasia Identifies Novel Targets for Pharmacological Control of Adrenal Cushing’s Syndrome

J. Bertherat, G. Assié, O. Chabre, 2010 .

Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.

J. Bertherat, G. Assié, O. Chabre, 2010, The Journal of clinical endocrinology and metabolism.

Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients.

J. Bertherat, X. Bertagna, P. Legmann, 2006, The Journal of clinical endocrinology and metabolism.

Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.

J. Bertherat, X. Bertagna, F. Tissier, 2008, The Journal of clinical endocrinology and metabolism.

Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease.

J. Bertherat, X. Bertagna, J. Coste, 2008, The Journal of clinical endocrinology and metabolism.

The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors.

A. Tabarin, J. Bertherat, X. Bertagna, 2002, The Journal of clinical endocrinology and metabolism.

Chapter 15 – Genetics of Adrenocortical Tumors (ACT) and Hypersecretory Syndromes

J. Bertherat, X. Bertagna, G. Assié, 2016 .

Chapter 16 – Genetics of Adrenocortical Tumors (ACT) and Hypersecretory Syndromes

J. Bertherat, X. Bertagna, L. Groussin, 2010 .

Mechanisms of Disease: adrenocortical tumors—molecular advances and clinical perspectives

J. Bertherat, X. Bertagna, L. Groussin, 2006, Nature Clinical Practice Endocrinology &Metabolism.

KDM1A inactivation causes hereditary food-dependent Cushing syndrome.

E. Letouzé, M. Sibony, J. Bertherat, 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism

J. Bertherat, J. Talbot, L. Groussin, 2020, World Journal of Surgery.

Visualization of Macroprolactinoma by 18F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1

L. Groussin, S. Gaujoux, A. Cottereau, 2018, Journal of the Endocrine Society.

p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?

V. Hervieu, P. Ruszniewski, F. Borson‐Chazot, 2014, Annales d'endocrinologie.

Cardiac Metastasis from Medullary Thyroid Cancers with Long-Term Survival under Vandetanib

P. Leprince, M. Schlumberger, A. Dohan, 2021, European Thyroid Journal.

Polyendocrinopathy Resulting From Pembrolizumab in a Patient With a Malignant Melanoma

J. Bertherat, J. Clerc, C. Lheure, 2017, Journal of the Endocrine Society.

The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors.

A. Tabarin, J. Bertherat, X. Bertagna, 2002, The Journal of clinical endocrinology and metabolism.

Aberrant Receptor-Mediated Cushing’s Syndrome

J. Bertherat, X. Bertagna, J. Luton, 2003, Hormone Research in Paediatrics.

Integrated genomic characterization of adrenocortical carcinoma

Eric Baudin, Martin Fassnacht, Franco Mantero, 2014, Nature Genetics.

Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma.

M. Sibony, J. Bertherat, E. Pasmant, 2017, Endocrine-related cancer.

Prolonged response to 177Lu-DOTATATE therapy of a bone marrow infiltration in a refractory thymic neuro endocrine tumor

J. Clerc, R. Coriat, F. Montravers, 2019, Investigational New Drugs.

PRKAR1A mutations in primary pigmented nodular adrenocortical disease

J. Bertherat, L. Groussin, L. Cazabat, 2006, Pituitary.

Adrenocortical carcinoma and pregnancy: clinical and biological features and prognosis.

J. Bertherat, X. Bertagna, J. Coste, 2010, European journal of endocrinology.

Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.

Bertrand Dousset, Aurélien de Reyniès, D. Rickman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.

Jacques Young, J. Bertherat, C. Stratakis, 2009, The Journal of clinical endocrinology and metabolism.

Heterogeneity of skin manifestations in patients with Carney complex.

J. Bertherat, X. Bertagna, N. Dupin, 2008, Journal of the American Academy of Dermatology.

Decreased steroidogenic enzyme activity in benign adrenocortical tumors is more pronounced in bilateral lesions as determined by steroid profiling in LC-MS/MS during ACTH stimulation test

J. Bertherat, G. Assié, J. Guibourdenche, 2022, Endocrine connections.

Atypical Presentation of Testicular Adrenal Rest Tumor (TART) Leading to Bilateral Partial Orchiectomy in a 31-Year-Old Adult Revealing Primary Adrenal Insufficiency with CYP11A1 Deficiency

M. Sibony, L. Groussin, C. Goursaud, 2021, Case reports in endocrinology.

Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.

P. Chanson, A. Tabarin, E. Baudin, 2015, European journal of endocrinology.

Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.

P. Chanson, A. Tabarin, E. Baudin, 2013, Human molecular genetics.

Frequency and incidence of Carney complex manifestations: a prospective multicenter study with a three-year follow-up.

A. Tabarin, F. Brucker-Davis, A. Feydy, 2020, The Journal of clinical endocrinology and metabolism.

Mutations and polymorphisms in the gene encoding regulatory subunit type 1‐alpha of protein kinase A (PRKAR1A): an update

E. Remmers, F. Faucz, J. Bertherat, 2010, Human mutation.

Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors.

M. Mavrakis, I. Bossis, J. Bertherat, 2008, Cancer research.

Large Deletions of the PRKAR1A Gene in Carney Complex

E. Remmers, I. Bossis, J. Bertherat, 2008, Clinical Cancer Research.

Large Deletions of the PRKAR1AGene in Carney Complex

E. Remmers, I. Bossis, C. Stratakis, 2008 .

A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds.

P. Chanson, J. Bertherat, X. Bertagna, 2006, The Journal of clinical endocrinology and metabolism.

Adrenal Pathophysiology: Lessons from the Carney Complex

J. Bertherat, L. Groussin, E. Jullian, 2005, Hormone Research in Paediatrics.

Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.

J. Bertherat, X. Bertagna, A. Louvel, 2002, The Journal of clinical endocrinology and metabolism.

Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma

M. Sibony, J. Bertherat, G. Assié, 2020, Endocrine connections.

Androgen Secreting Adrenocortical Tumors , 08-0324 Revised 1 Sex steroids in androgen-secreting adrenocortical tumors : clinical and hormonal features in comparison with non tumoral causes of androgen excess

V. Viallon, J. Bertherat, X. Bertagna, 2008 .

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.

J. Bertherat, X. Bertagna, F. Tissier, 2010, The Journal of clinical endocrinology and metabolism.

Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.

J. Bertherat, X. Bertagna, G. Assié, 2014, European journal of endocrinology.

Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.

P. Chanson, P. Caron, A. Barlier, 2013, The Journal of clinical endocrinology and metabolism.

ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.

M. Sibony, J. Bertherat, X. Bertagna, 2013, The New England journal of medicine.

Dual Specificity Phosphatase 5, a Specific Negative Regulator of ERK Signaling, Is Induced by Serum Response Factor and Elk-1 Transcription Factor

F. Cormier, M. Catelli, L. Groussin, 2015, PloS one.

Cushing's disease.

J. Bertherat, X. Bertagna, L. Groussin, 2009, Best practice & research. Clinical endocrinology & metabolism.

Molecular perspectives in differentiated thyroid cancer.

L. Groussin, C Buffet, L Groussin, 2015, Annales d'endocrinologie.

Redifferentiation of radioiodine-refractory thyroid cancers.

L. Leenhardt, L. Groussin, C. Dupuy, 2020, Endocrine-related cancer.

MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer

J. Bertherat, L. E. El Khattabi, F. Cormier, 2019, Oncotarget.

A Hungry Bone Syndrome Predicted by 18F-Fluorocholine PET/CT.

L. Groussin, M. Gauthé, Fritz-Line Vélayoudom, 2019, Clinical nuclear medicine.

Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma

M. Sibony, J. Bertherat, G. Assié, 2022, European journal of endocrinology.

Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma.

A. Tabarin, E. Korpershoek, E. Baudin, 2019, JAMA oncology.

Lung carcinoid tumors with Diffuse Idiopathic Pulmonary NeuroEndocrine Cell Hyperplasia (DIPNECH) exhibit pejorative pathological features.

L. Fournel, G. Chassagnon, M. Alifano, 2021, Lung cancer.

Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-Dependent Cushing Syndrome Patients.

J. Bertherat, G. Assié, J. Guibourdenche, 2022, European journal of endocrinology.

ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.

F. Brucker-Davis, F. Beuschlein, J. Bertherat, 2015, The Journal of clinical endocrinology and metabolism.

Succinate detection using in vivo 1H-MR spectroscopy identifies germline and somatic SDHx mutations in paragangliomas

P. Bénit, B. Tavitian, P. Rustin, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Rapid control of severe ectopic Cushing's syndrome by oral osilodrostat monotherapy.

J. Bertherat, L. Groussin, F. Tenenbaum, 2021, European journal of endocrinology.

ATF4 Degradation Relies on a Phosphorylation-Dependent Interaction with the SCFβTrCPUbiquitin Ligase

Tsonwin Hai, R. Benarous, I. Lassot, 2001, Molecular and Cellular Biology.

When adrenal Cushing's and phaeochromocytoma meet

F. Tissier, B. Dousset, L. Groussin, 2012, The Lancet.

MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data

J. Clerc, L. Groussin, O. Huillard, 2023, Cancers.

Restoring Radioiodine Uptake in BRAF V600E–Mutated Papillary Thyroid Cancer

F. Goldwasser, J. Clerc, L. Groussin, 2017, Journal of the Endocrine Society.

Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer.

J. Clerc, S. Garinet, L. Groussin, 2021, Thyroid : official journal of the American Thyroid Association.

Surgical procedure for multifocal duodenopancreatic gastrinomas in a MEN-1 patient (with video).

B. Dousset, L. Groussin, S. Gaujoux, 2019, Journal of visceral surgery.

The Great Imitator in Endocrinology: A Painful Hypophysitis Mimicking a Pituitary Tumor.

J. Bertherat, N. Dupin, L. Groussin, 2015, The Journal of clinical endocrinology and metabolism.

Amiodarone-induced thyrotoxicosis.

L. Groussin, L. Bricaire, Louis Schubert, 2020, Annales d'Endocrinologie.

Identification of predictive criteria for pathogenic variants of the Primary Bilateral Macronodular Adrenal Hyperplasia gene ARMC5 in 352 unselected patients.

A. Tabarin, J. Bertherat, G. Assié, 2022, European journal of endocrinology.

Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia.

A. Tabarin, Jacques Young, J. Bertherat, 2013, The New England journal of medicine.

Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome.

J. Bertherat, X. Bertagna, J. Coste, 2010, European journal of endocrinology.

Long-term outcome after adrenalectomy for incidentally diagnosed subclinical cortisol-secreting adenomas.

H. Gouya, B. Dousset, L. Groussin, 2016, Surgery.

Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT, illustrative cases and pitfalls.

J. Talbot, F. Montravers, S. Périé, 2022, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing's Syndrome.

J. Bertherat, L. Groussin, X. Declèves, 2023, Journal of pharmaceutical and biomedical analysis.

18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients.

M. Bienvenu, J. Bertherat, X. Bertagna, 2009, The Journal of clinical endocrinology and metabolism.

Authors’ Reply: 18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism

L. Groussin, S. Gaujoux, M. Gauthé, 2021, World Journal of Surgery.

Outpatient thyroid remnant ablation using repeated low 131-iodine activities (740 MBq/20 mCix2) in patients with low-risk differentiated thyroid cancer.

J. Clerc, L. Groussin, F. Leger, 2012, The Journal of clinical endocrinology and metabolism.

ARMC 5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia : Clinical and Functional Consequences

F. Brucker-Davis, F. Beuschlein, J. Bertherat, 2015 .

ARMC 5 Mutations in Macronodular Adrenal Hyperplasia with Cushing ’ s Syndrome

M. Sibony, J. Bertherat, X. Bertagna, 2013 .

[Update in adrenal imaging].

L. Groussin, F. Tenenbaum, Marine Lataud, 2014, Presse medicale.

Is Carney complex a breast cancer predisposing syndrome? prospective study of 50 women

A. Tabarin, J. Bertherat, G. Assié, 2020 .

Next Generation Sequencing and Association Studies in Familial Nonmedullary Thyroid Carcinoma: Let’s Choose Appropriate Controls

P. de Mazancourt, L. Groussin, J. Ropers, 2017, European Thyroid Journal.

Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B–Secreting Adrenocortical Carcinoma

M. Bienvenu, M. Sibony, J. Bertherat, 2017, Journal of the Endocrine Society.

Larotrectinib-Enhanced Radioactive Iodine Uptake in Advanced Thyroid Cancer.

J. Clerc, L. Groussin, O. Huillard, 2020, The New England journal of medicine.

Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R.

J. Bertherat, X. Bertagna, L. Groussin, 2000, The Journal of clinical endocrinology and metabolism.

Insights into the Molecular Biology of Adrenocortical Tumors

J. Bertherat, X. Bertagna, C. Gicquel, 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center.

J. Haymann, J. Talbot, S. Christin‐Maitre, 2023, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Benjamin J Raphael, Benjamin J. Raphael, Richard A. Moore, 2016, Cancer cell.

Possible primary thyroid NUT carcinomas with NSD3: NUTM1 translocation revealed by RNA Sequencing- A report of two cases.

C. Tlemsani, L. Leenhardt, L. Groussin, 2022, Thyroid.

Long-Term Control of Hypercortisolism by Vandetanib in a Case of Medullary Thyroid Carcinoma with a Somatic RET Mutation

N. Burnichon, L. Groussin, N. Lahlou, 2017 .

Long-Term Control of Hypercortisolism by Vandetanib in a Case of Medullary Thyroid Carcinoma with a Somatic RET Mutation.

M. Alifano, N. Burnichon, L. Groussin, 2017, Thyroid.

Positive Correlation Between 18F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas

M. Sibony, J. Bertherat, G. Assié, 2023, Clinical nuclear medicine.

18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease

L. Groussin, R. Libé, Jean-François Jazeron, 2018, Endocrine.